A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World Setting
Clinical trial NCT05487703 · COMPLETED
Trial details
- NCT number
- NCT05487703
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-14
- Primary completion
- 2022-12-23
- Enrollment
- 318
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.